Mangalam Drugs & Organics (NSE:MANGALAM) Interest Expense : ₹-139 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mangalam Drugs & Organics's interest expense for the three months ended in Dec. 2023 was ₹ -33 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-139 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mangalam Drugs & Organics's Operating Income for the three months ended in Dec. 2023 was ₹ 33 Mil. Mangalam Drugs & Organics's Interest Expense for the three months ended in Dec. 2023 was ₹ -33 Mil. Mangalam Drugs & Organics's Interest Coverage for the quarter that ended in Dec. 2023 was 1.01. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mangalam Drugs & Organics Interest Expense Historical Data

The historical data trend for Mangalam Drugs & Organics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Interest Expense Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-64.96

-63.21

-72.02

-2.97

-139.17

Mangalam Drugs & Organics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-34.12	-32.45	-33.10	-39.51

Mangalam Drugs & Organics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-139 Mil.

Mangalam Drugs & Organics (NSE:MANGALAM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mangalam Drugs & Organics's Interest Expense for the three months ended in Dec. 2023 was ₹-33 Mil. Its Operating Income for the three months ended in Dec. 2023 was ₹33 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was ₹0 Mil.

Mangalam Drugs & Organics's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	33.494	/	-33.095
	=	1.01

The higher the ratio, the stronger the company's financial strength is.

Mangalam Drugs & Organics (NSE:MANGALAM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (NSE:MANGALAM) » Definitions » Interest Expense

Traded in Other Exchanges

532637:India

Address

239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (NSE:MANGALAM) Headlines

No Headlines